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Thispilotstudyaimedtoidentifytheeﬀectsofa6-month,multimodalexerciseprogramonclinicalandgaitparametersinpatients
with Parkinson’s disease. Two groups of participants were enrolled in the study: Trained Group (TG) and Control Group (CG).
Individuals in the TG exercised three times a week for 24 weeks (in a multimodal exercise program), while the CG participants
maintained their regular activity level. Participants in both the TG and the CG were assessed at pre- and posttest by clinical
rates and the spatiotemporal parameters of self-paced walking. The two groups were not signiﬁcantly diﬀerent in demographic,
clinical, and gait data at baseline. There were no signiﬁcant diﬀerences between groups for clinical data at posttest. The purposed
multimodal exercise program has found improvement in some kinematic gait parameters for the TG. Further study in the form of
randomized controlled trial would be required to establish eﬀectiveness of the intervention.
1.Introduction
Parkinson’s disease (PD) aﬀects approximately 0.3% of the
population worldwide,andfrom1%to2%ofindividualsare
m o r et h a n6 0y e a r so l d[ 1]. In Brazil, a recent population-
based cohort study showed PD to have a prevalence of
3.3% [2]. PD is a neurodegenerative pathology characterized
by progressive degeneration of the dopamine-containing
neurons in the substantia nigra pars compacta. The decreased
amount of dopamine compromises the optimum amount
of neuromotor impulses required for the accurate control
of muscle activation. As a consequence, PD patients show
motor disturbances (e.g., resting tremor, rigidity, postural
instability, and gait disorders). The clinical parameters of
PD patients tend to get worse progressively [3], even though
therapeutic interventions have shown some beneﬁts to pa-
tients [4, 5].
Gait disorders are one of the most incapacitating signs
of PD. The negative impact of gait disorders includes immo-
bility (causing loss of independence) and the risk of falling.
Therefore, a large number of studies have been performed to
measure gait parameters in PD patients. These studies have
shown that Parkinsonian gait is characterized by shortened
step and stride length and reduced velocity [6, 7]. While ca-
dence typically is not modiﬁed, in some cases, as a possible
adaptation to amplitude regulation disorder, it appears to
increase [6]. These gait features progressively worsen with
the advance of the disease, which severely limits patients’
mobility and quality of life [8, 9].
Researchers have examined empirical studies to establish
eﬀective interventions that can improve the gait parameters
of PD patients. For example, a recent meta-analysis revealed
that exercise trials may promote beneﬁts related to gait in
PD patients [10]. Some studies achieved satisfactory results2 ISRN Neurology
by applying speciﬁc exercise programs for locomotion (e.g.,
body-weight-supported exercises on a treadmill [11, 12],
walking on a treadmill at a speed greater than overground
walking speed [13], use of visual and auditory cues [14]), for
l o w e rl i m bs t r e n g t h[ 15] and for coordination and sensory
attention [4, 5]. Thus, we can speculate that speciﬁcity of
exercise is not a critical factor in improving gait parameters
of PD patients.
Although promising, studies of exercise in PD have been
limited in scope (program duration and speciﬁcity). Most
have addressed the eﬀects of short-term (typically imple-
m e n t e do v e r4t o1 2w e e k s )s p e c i ﬁ ce x e r c i s ep r o g r a m s .T h e
beneﬁts of longer and nonspeciﬁc exercise intervention
remain poorly understood [16, 17]. To our knowledge, this
is the ﬁrst study addressing the eﬀects of a 6-month, multi-
modal exercise program on gait parameters in PD patients.
Our research group has previously demonstrated a positive
eﬀect of the purposed program on executive functions [16]
and balance [17].
Within this context, the current study employed a broad-
er approach, one which utilizes a multimodal exercise pro-
gram, in an attempt to improve the gait parameters of PD
patients.Inaddition,manyexercisetrialstudieshaveignored
the overall changes in symptoms or disease severity [18, 19].
Sage and Almeida [4] suggested that in exercise trials it is
crucial for investigators to consider eﬀects on clinical symp-
toms in conjunction with changes in gait. Therefore, the aim
of this study was to identify the eﬀects of a 6-month, multi-
modal exercise program on clinical and kinematic gait pa-
rameters in PD patients. We expected to observe positive
changes in PD patients’ symptoms and gait parameters after
their participation in the program.
2. Methods
This study adhered to the guidelines of the Declaration of
Helsinki and was approved by the local Ethics Committee.
All patients signed a consent form before involvement in the
study.
2.1. Participants. The participants were recruited through
the assistance of physicians (neurologists and psychiatrists)
from Rio Claro, S˜ ao Paulo, Brazil, who encouraged their
patients to participate in the study. Thirty-four patients
with PD volunteered to participate in the study. All had a
diagnosis of idiopathic PD, with no other major neurological
problems.DiagnosisofPDwasmadeaccordingtotheUnited
Kingdom Parkinson’s disease Society Brain Bank clinical
criteria for idiopathic PD. The participants were assigned to
two groups according to personal interest (the participants
chose which group they preferred to be part of): Trained
Group (TG; n = 24) and Control Group (CG; n = 10).
Participants of both groups were sedentary prior to the
study (subjects had followed any training program during
last year). Individuals in the TG participated in a 6-month,
multimodal exercise program described under the training
protocol section. Participants in the CG kept to their same
daily routines and did not participate in any regular or
structured exercise during the study period. Table 1 shows
demographic data at baseline for the 29 individuals who
completed the study. Levodopa intake remained unchanged
for all participants during the intervention. Inclusion criteria
were disease in Stages I–III of the Hoehn and Yahr Rating
Scale (H&Y) [20], independent walker, and no cognitive
impairment, as judged by the Mini-Exam of Mental Status
(MEMS) [21]. Brucki et al.’s [22] suggestions for utilization
of the MEMS in Brazil (cutoﬀ score according to educational
level) were followed to screen for cognitive impairment.
Exclusion criteria were any history of orthopedic, cardio-
vascular, or psychiatric disorders, as judged by the clinical
assessment. No participant suﬀered from freezing of gait.
2.2. Training Protocol. The aim of the multimodal exercise
program was to develop the patients’ functional capacities,
cognitive functions, posture, and locomotion. In contrast
to speciﬁc programs, this one targeted a global (holistic)
improvement of PD patients. It is composed of a variety
of activities that simultaneously focus on other components
of functional capacity, such as muscular resistance (speciﬁc
exercises for gastrocnemius, quadriceps femoralis, ham-
string, rectus abdominalis, and trunk dorsal muscles), motor
coordination (rhythmic activities), and balance (recreational
motor activities). These components were selected because
they seem to be aﬀected by PD and could represent under-
lying mechanisms to gait impairments. The multimodal pro-
gramtookplaceovera6-monthperiod(72sessions,3timesa
week, and 60 minutes per session). Each session consisted of
ﬁve parts (warm-up, preexercise stretching, exercise session,
cool down and postexercise stretching). The main exercise
session lasted 40 minutes. The program was divided into six
phases; each phase was composed of 12 sessions, each lasting
approximatelyonemonth.Attheendofeachphasetherewas
a progressive increase of load (Table 2). In each session, three
diﬀerent participants utilized a heart rate monitor (Polar)
to assess the intensity of the session. Heart rate during the
main exercise sessions remained between 60% and 80% of
maximum heart rate (220 minus the participant’s age in
years).
Each participant was required to participate in at least
70% of the sessions in order to be included in the data anal-
ysis. No participant of the TG was absent from the interven-
tion program for more than ﬁve consecutive sessions. The
exercise program was supervised by at least three physical
education professionals each time. No adverse events with
the intervention were perceived or reported.
2.3. Evaluation. Participants were tested before commencing
the multimodal program (pretest) and upon completion
(posttest). All assessments were carried out in the morning,
in the “on-medication” state, 1 hour after participants’ ﬁrst
morning dose of medication.
A neuropsychiatrist performed a clinical assessment in
order to test participants on the Uniﬁed Parkinson’s Disease
Rating Scale (UPDRS) [23], MEMS, and H&Y. Higher scores
on the UPDRS signify higher deﬁcit levels of the disease.
Conversely, higher scores on the MEMS represent a moreISRN Neurology 3
Table 1: Characteristics of participants.
TG (n = 19) CG (n = 10) P value
Mean (sd) Range Mean (sd) Range t-test
Age (years) 67.5 (8.3) 52–81 71.3 (8.1) 55–84 0.242
Body height (cm) 159.4 (8.9) 142.8–176.5 160.8 (9.1) 147.1–173.7 0.694
Body mass (kg) 68.9 (13.5) 46.5–91.6 63.5 (9.8) 46–75 0.268
Years since diagnosis 3.8 (3.9) 1–19 4.4 (2.8) 1–10 0.695
Legend: TG: Trained group; CG: Control Group.
Table 2: Designed phases of the 6-month, multimodal exercise program with progressive increments on load and complexity for people
with Parkinson’s disease (adapted from Tanaka et al. [16]).
Phases
Capacities
Coordination Muscular Resistance Balance
Phase 1 Upper and lower limbs movements. Exercises without weights. Recreational activities that stimulated
the vestibular system.
Phase 2 Trunk movements were added to
upper and lower limbs movements.
Light-weight equipment (hoops,
ropes, and batons).
Recreational activities that stimulated
the visual and vestibular systems.
Phase 3 Trunk movements were substituted by
head movements.
Heavier equipments (barbells, ankle
weights, medicine balls).
Recreational activities that stimulated
the visual and somatossensorial
systems.
Phase 4 Head, trunk, and upper and lower
limb movements.
Load was again increased with heavier
equipment for resistance training
(increase of intensity) or increased
repetitions (increased volume).




Four diﬀerent movement sequences,
two of which were the same for upper
and lower limbs and two other
sequences that alternated movements
for upper and lower limbs in place and
in movement.
Exercises were done with weights: leg
press, pulley, seated cable rows, peck
deck, and bench press. Load was
adjusted according to patients’
convenience (in two series of 15
repetitions).
Recreational activities included static
balance, dynamic balance, half-turn,
and complete turn (all with visual
cues).
Phase 6
Four sequences of diﬀerent
movements, two sequences of
alternating movement for upper and
lower limbs and two sequences of
diﬀerent movement for upper and
lower limbs, with or without trunk
movement and equipment (balloons,
balls, hoops, and rope).
The same exercises with load increase.
Series of 15 repetitions were added.
Recreational activities were composed
of activities with tactile cues.
preserved cognitive function. For data analysis, scores on the
UPDRS subsections I (Mentation, Behavior, and Mood), II
(Activities of Daily Living), and III (Motor) were considered
separately. The rater was blinded as to the study purpose and
to the groups in which the patients participated.
The walking task required participants to walk, at a self-
paced speed, on a pathway 8m long by 1.4m wide, which
was covered with a black rubber carpet, 3mm thick. Three
trials were performed. For the kinematic data recording, two
passive markers (reﬂective, adhesive Styrofoam, 15mm in
diameter) were attached to the following anatomic land-
marks: lateral face of the right calcaneus and medial face
of the left calcaneus. The images of the right sagittal plane
of one stride at center of the pathway were recorded with a
frequency of 60Hz by one digital camcorder (JVC, GR-DVL
9800), generating 2D kinematic data. Markers were digitized
automatically on Digital Video for Windows (DVIDEOW)
software [24]. The x and y coordinates for each marker were
transformed into a metric system by means of a bidimen-
sional reference system, with four control points, and with a
length of 1478mm and a height of 1480mm. An experiment
error of 4.61mm was obtained. Raw data were ﬁltered using
a low-pass, second-order digital Butterworth ﬁlter, with a
cutoﬀ frequency of 5Hz in the Matlab 6.5 environment. A
Matlab algorithm calculated the gait-dependent variables by
manipulating the matrix created bythe DVIDEOW software.
The following gait-dependent variables were calculated
on the central right stride, from heel contact to the next
heelcontact:stridelength,strideduration,stridevelocity,ca-
dence, double-support phase duration, single-support phase
duration, and swing phase duration [25, 26]. The values for
each dependent variable of all three trials per participant
were considered for statistical analysis. This particular set
of gait parameters was chosen because it has been shown
to be altered in PD and to be a sensitive tool to identify
changes in gait after the enrolment in exercise programs4 ISRN Neurology
[4, 6, 13, 25, 26]. The personnel conducting gait analyses
were also blinded as to the study purpose and to the groups
in which the patients participated.
2.4. Statistical Analysis. For all outcome measures, unrelated
sample Student’s t-tests were employed for between group
comparisons at the baseline. Multivariate analyses of vari-
ance (MANOVA) were employed, including group (Trained
versus Control) and time (pretest versus posttest) as factors,
with repeated measures on the second factor. Separate
MANOVA analyses included clinical variables and gait vari-
ables, respectively. Univariate analyses were employed when-
ever MANOVA revealed interaction between the factors.
Signiﬁcant interactions were followed up with post hoc
comparisons using Tukey honestly signiﬁcant diﬀerence
(HSD) procedure. The statistical analysis employed SPSS for
Windows, with an alpha level of 0.05.
3. Results
Five participants in the TG dropped out of the study: three
due to the time commitment, one moved to another city,
and one died. Thus, data from 19 individuals who completed
the training protocol (10 women and 9 men) and 10 control
participants (4 women and 6 men) were used for analysis.
Although the participants’ distribution procedure was not
random, the two groups were not signiﬁcantly diﬀerent in
demographic, clinical, and gait data at baseline. P values of
t-tests are outlined in Tables 1, 3,a n d4,r e s p e c t i v e l y .
The ﬁrst MANOVA did not reveal interactions between
factors (Wilks’ Lambda = 0.846, F(5,23) = 0.840, P = 0.535)
forclinicalvariables.Clinicaldatafrompre-andposttestsare
shown in Table 3.
The second MANOVA revealed interactions between
factors (Wilks’ Lambda = 0.838, F(7,79) = 2.184, P = 0.044)
for gait variables. Univariate analysis for interaction between
groups and time revealed signiﬁcant diﬀerences for stride
length (F(1,85) = 8.205, P = 0.005), and stride velocity
(F(1,85) = 9.290, P = 0.003), and trend for stride duration
(F(1,85) = 3.608, P = 0.061). Tukey’s HSD post hoc test
revealed that only the TG group had a statistically signiﬁcant
improvement of these gait parameters at posttest when com-
pared with pretest. Gait data for pre- and posttests are shown
in Table 4.
4. Discussion
The aim of this pilot study was to identify the eﬀects of
a 6-month, multimodal exercise program on clinical and
kinematic gait parameters in PD patients. Primarily, it is
important to attest that the applied intervention had no
adverse event, which indicates that it could be carried out by
people with PD in a safe manner. The current study brings
a new approach to the possibilities that physical exercise can
oﬀer for rehabilitation in PD.
The purposed multimodal exercise program has found
improvement in some kinematic gait parameters, but not in
clinical data, for the TG. Although promising, these results
should be interpreted with caution, as the current study
hassomeimportantmethodological limitations:(i)selection
bias in the group assignment; (ii) the lack of blinding of
participants to group assignment; (iii) sample size.
Regarding kinematic gait parameters, the proportional
durations of stride phases and cadence did not change as
an eﬀect of the enrolment in the program. The main gait-
related ﬁndings after participation in the program include
improvements in stride length, stride duration, and stride
velocity (7.7%, 8.5%, and 14%, resp.). The TG approached
or reached the accepted means for Brazilians healthy elderly
individuals—stride length: 117cm; stride duration: 0.99s;
stride velocity: 120cm/s [27]. Improvements in gait param-
eters have been shown to be of clinical relevance for elderly
[28, 29], which would represent positive impact on quality
of life. Improvement in usual gait speed after a follow-up
of one year predicts a substantial reduction in mortality
[28]. Also, Cesari et al. [29] have suggested that usual gait
speed of less than 1m/s identiﬁes persons at high risk of
health-related problems (persistent severe lower extremity
limitation, death, and hospitalization) in well-functioning
older people. With this regard, it is important to note that
the participants of TG have obtained a stride velocity value
higher than this cutoﬀ point at posttest.
In addition to current ﬁndings, our group has previously
demonstrated a positive eﬀect of the purposed program
on executive functions [16] and on functional mobility
and balance [17] in PD patients. Since multimodal exercise
programscouldhavepositive impactonmotorandcognitive
outcomes [16, 17], they should be further explored as a pos-
sible intervention tool for PD patients.
Both the clinical and gait parameters of PD patients
t e n dt ow o r s e np r o g r e s s i v e l y .A l v e se ta l .[ 30] found similar
mean annual declines in the UPDRS-III score and the H&Y
staging, at 3.1% and 3.2%, respectively. Also, the UPDRS-
II score declined 3.5% per year. Our ﬁndings do not point
to a positive eﬀect of purposed program over clinical data.
It seems important to note that none of the clinical or gait
parameters worsened for the CG in the study. It could be
argued that six months does not represent enough time to
observe signiﬁcant declines in clinical or gait parameters of
mildtomoderatePDpatients.Thus,itisanimportantaspect
to guide future long-term exercise trials: periods longer than
six months should be considered.
The rationale to choose a multimodal exercise interven-
tion derived from the fact that the speciﬁcity of exercises is
unclear relative to exercise trials in the rehabilitation litera-
ture for PD patients. Researchers have had diﬃculty reaching
a consensus on which type of exercise is most beneﬁcial
for gait parameters. For example, body-weight supported
exercises on a treadmill (three days a week for four weeks)
resulted in signiﬁcant gait and symptom improvements [11].
Walking on a treadmill at a speed greater than overground
walking speed (three times per week for eight weeks) was
also eﬃcient in ameliorating gait parameters such as walking
speed, stride length, and cadence [13]. Nieuwboer et al. [14]
employed visual and auditory cues, as well as verbal instruc-
tions (three times per week for six weeks), which appeared
to help increase the stride length of PD patients. The useISRN Neurology 5
Table 3: Means and standard deviations for each clinical dependent variable at pre and posttest and P-value for the comparison at baseline.
Measure
Pretest
P value at baseline
TG versus CG
Posttest
Interaction between factors TG (n = 19) CG (n = 10) TG (n = 19) CG (n = 10)
Mean (sd) Mean (sd) Mean (sd) Mean (sd)
H&Y 1.5 (0.75) 1.6 (0.88) 0.688 1.6 (0.73) 1.7 (0.85) ns
UPDRS-I 3.9 (2.7) 2.8 (1.4) 0.143 3.6 (2.4) 2.5 (1.9) ns
UPDRS-II 12.2 (7.4) 12.2 (4.9) 0.997 11.2 (7.2) 12.5 (6.7) ns
UPDRS-III 22 (12.7) 28.4 (9.5) 0.175 22.5 (14.4) 28.9 (9.1) ns
MEMS 25.8 (4.1) 23.7 (5.5) 0.256 25.8 (4) 24.7 (4.5) ns
Legend: TG: Trained group; CG: Control Group; H&Y: Hoehn and Yahr Rating Scale; UPDRS: Uniﬁed Parkinson’s Disease Rating Scale; MEMS: Mini-Exam
of Mental Status; ns: nonsigniﬁcant interaction between factors.
Table 4: Means and standard deviations for each gait dependent variable at pre and posttest and P-value for the comparison at baseline.
Measure
Pretest
P value at baseline
TG versus CG
Posttest
Interaction between factors TG (n = 19) CG (n = 10) TG (n = 19) CG (n = 10)
Mean (sd) Mean (sd) Mean (sd) Mean (sd)
Stride length (cm) 95.1 (14.8) 94.8 (20.7) 0.95 102.4 (15.5) 96.6 (25.7)
∗TG: post > pre
CG: post = pre
Stride duration (s) 1.06 (0.17) 1.07 (0.1) 0.683 0.97 (0.11) 1.03 (0.1)
trend
TG: post < pre
CG: post = pre
Stride velocity (cm/s) 92.7 (21.1) 90.2 (24.9) 0.625 105.7 (15.5) 94.8 (28.8)
∗TG: post > pre
CG: post = pre
Cadence (strides/s) 0.97 (0.13) 0.94 (0.09) 0.387 1.04 (0.12) 0.98 (0.09) ns
Swing phase (%) 36.5 (4.1) 36.3 (2.4) 0.771 37.2 (2.3) 36.9 (2.6) ns
Single support (%) 37.5 (3.7) 37.6 (3.4) 0.906 38.3 (2.3) 38.3 (2.7) ns
Double support (%) 26 (7.3) 26.1 (4.9) 0.924 24.5 (4) 24.8 (4.5) ns
Legend: TG: Trained group; CG: Control Group; ∗:signiﬁcant interaction between factors (P<0.05); ns: nonsigniﬁcant.
of resistive training for lower limbs and abdominal muscles
(twice a week for eight weeks) reveals a signiﬁcant increase
in stride length and velocity [15]. Sage and Almeida [4, 5]
demonstrated that sensory, attention-focused exercise (three
days a week for 12 weeks) can beneﬁt the symptoms and
gaits of PD patients. In this context, we can speculate that
speciﬁcity of exercise is not a critical factor in improving gait
parameters.
All of these exercise trials were designed speciﬁcally
to improve gait parameters and had short-term durations
(between 4 and 12 weeks). However, we suggest that PD
patients should be enrolled in exercise programs for long
periods (at least for 24 weeks), and that such programs also
should attempt to correct a range of impairments caused
by PD, which ultimately could result in improvements for
qualityoflife.Ourﬁndingssuggestthatthiscouldbepossible
with a 6-month, multimodal exercise program. In addition,
long-term exercise programs could provide another beneﬁt:
ﬁghting against disease progression (protective eﬀect of
exercise). Over short periods, it is diﬃcult to assess the
eﬀects of exercise related to the progression of PD. This is
supportedbythefactthatexercisestudiesofananimalmodel
of PD have demonstrated increased survival of nigrostriatal
dopaminergic neurons, suggesting a potential protective
eﬀect of exercise as well [31]. Therefore, it may be argued
that these beneﬁts could be achieved by a physically active
lifestyle.
I tw ouldbeusefult odesignotherstudiest ohelpimpr o v e
the understanding of how exercise trials aﬀect the gait
parameters of PD patients. Future long-term exercise trials
should include midpoint assessment to verify speciﬁc short-
and long-term exercise-related changes on clinical and gait
parameters. It could also be useful to review walking tasks
that are utilized to evaluate gait. For example, walking on a
treadmilloronawalkwayisdiﬀerentthanwalkingindomes-
tic and community environments. Locomotion over uneven
terrains (obstacle crossing task) [26], or under postural
threat (constrained and elevated ﬂoor) [25], is a more com-
plex tasks and should be explored relative to PD patients en-
rolled in exercise programs.
In conclusion, the purposed 6-month, multimodal exer-
cise program has found improvement in some kinematic
gait parameters of mild-to-moderate idiopathic PD patients.
Further study in the form of a randomized controlled trial
would be required to establish eﬀectiveness of our program.
The current ﬁndings should be useful in guiding the design
of such studies.6 ISRN Neurology
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